pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines 96

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 96

European Pharmaceutical Review

NOVEMBER 23, 2023

Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. The immuno-oncology therapeutic market In analysis published by GlobalData in July 2023, immuno-oncology therapies have emerged as a novel treatment category.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 115

ISPE

SEPTEMBER 21, 2022

However, the global public health driver to execute these projects in record time, and deliver commercially approved vaccines, in large volumes, was unprecedented and therefore deserves recognition for Social Impact. Janssen Biologics provides clinical and commercial manufacturing services of complex medicines and vaccines.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

Pharmaceutical Technology

FEBRUARY 8, 2023

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion between Dec 31, 2021 and Dec 31, 2022, owing to expansion in its vaccine and oncology portfolio.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 78

Pharmaceutical Technology

APRIL 21, 2023

US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The company plans to optimise strategies around sales, distribution and marketing of the drug to increase its access.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here. billion ($4.1

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

European Pharmaceutical Review

MARCH 11, 2024

For example, rising ambient temperatures and ingress of mould from items entering cleanrooms, has resulted in some vaccine and pharmaceutical companies in Europe experiencing increased contamination. Ahmed et al.

Sterile Compounds 98

Sterile Compounds Compounding Packaging Pharmaceutical Companies 98

ISPE

SEPTEMBER 29, 2023

For more than 240 years, Takeda has focused on delivering transformative treatments in the therapeutic areas of gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Applications must be submitted by 4 December 2023. WANT TO LEARN MORE? Register Now!

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Patient Care 52

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced an 18% drop in company filings mentions of orphan designated drugs in Q1 2023 compared with the previous quarter, with the highest share accounted for by Horizon Therapeutics with 50% year-on-year increase, according to GlobalData’s analysis of over 182 pharmaceutical company filings.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

pharmaphorum

NOVEMBER 4, 2022

While most supply chains were impacted by the Covid-19 pandemic, the demands it placed on pharmaceutical and medical supply chains were immense and underlined the importance of transparency and security. A number of pilot projects are underway to speed the way to a blockchain solution for the pharma industry.

Pharmaceutical Companies 123

Pharmaceutical Companies Pharmaceutical Companies Vaccines 123

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

Vaccines 40

Vaccines Immunization Packaging Pharmaceutical Companies 40

Pharmaceutical Technology

APRIL 12, 2023

Taiwan Shionogi, a subsidiary of the Japanese pharmaceutical company Shionogi, has filed an application with the Taiwan Food and Drug Administration (TFDA) to obtain emergency use authorisation (EUA) for ensitrelvir fumaric acid (ensitrelvir). It targets Covid-19 patients who were asymptomatic or only had mild symptoms.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 59

Roots Analysis

NOVEMBER 6, 2023

In this context, several industry players have demonstrated high inclination towards supporting and advancing the development of next generation RNA-based therapeutics, vaccine and technologies. The below given figure provides an illustrative summary of the benefits of next generation RNA-based vaccines and RNA-based therapeutics market.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

DECEMBER 12, 2023

Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. Final results from the TELLOMAK study are expected by the end of 2023, as well as preliminary data from the Phase Ib trial in PTCL.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

Hospital Pharmacy Europe

DECEMBER 5, 2024

mRNA vaccines: from Covid-19 and beyond The rapid success of messenger ribonucleic acid (mRNA) vaccines during the Covid-19 pandemic set the stage for broader applications, and in 2024, mRNA technology expanded significantly. Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat Commun 2024;15:1553.

Vaccines 59

Vaccines Patient Care Compounding Pharmaceutical Companies 59

Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Source: GlobalData Pharmaceutical Intelligence Center.

Packaging 59

Packaging Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

FEBRUARY 3, 2025

In recent years, leading pharmaceutical companies, such as Sanofi, successfully launched smart factory programmes. Li Yang, PhD Vice President of CMC Development, Altruist Biologics Dr Li Yang brings over 10 years of industry expertise in biological drug and vaccine development, manufacturing and registration.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

31, 2023, as an interchangeable biosimilar to Stelara. It is made by the pharmaceutical company Amgen, Inc. In April of 2024, the FDA approved Selarsdi (ustekinumab-aekn), a Stelara biosimilar made by the pharmaceutical companies Alvotech and Teva Pharmaceuticals. It is not an interchangeable biosimilar.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

Roots Analysis

OCTOBER 3, 2023

Key Trends that are Shaping up the Global Bioreactors and Fermenters Market As per a recent market report by Roots Analysis, more than 255+ companies are currently involved in manufacturing bioreactors and fermenters, across the globe for the production of biopharmaceuticals, such as antibodies, vaccines, cell and gene therapies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

ISPE

SEPTEMBER 12, 2023

Empowered by Community; A Mentor ISPE Experience Trudy Patterson Tue, 09/12/2023 - 08:23 iSpeak Blog iSpeak Empowered by Community; A Mentor ISPE Experience Amy Washco 12 September 2023 As a mid-career employee, I’ve earned expertise in many areas but feel I still have much to learn. More importantly, I feel have much left to offer.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

The Checkup by Singlecare

JUNE 7, 2024

Humira is a brand-name medication made by the pharmaceutical company AbbVie, Inc. Cyltezo is an interchangeable biosimilar (similar to a generic, but for biologic drugs like Humira) made by Boehringer Ingelheim Pharmaceuticals, Inc. It became available in the United States in July of 2023.

Vaccines 52

Vaccines Insurance FDA Insurance Coverage 52

Pharmaceutical Technology

DECEMBER 27, 2022

However, despite external pressures, major pharma deals still came to pass, which some experts say could be a harbinger for things to come in 2023. The Covid-19 pandemic pushed most markets into free fall, leading to increased wariness for completing large mergers and acquisitions (M&As) in the pharmaceutical sector.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

The Checkup by Singlecare

JUNE 7, 2024

Made by the pharmaceutical company Janssen Biotech, Inc., While you are on Stelara, you should not receive live vaccines , including MMR, varicella, rotavirus, nasal flu vaccine, or the Bacillus Calmette–Guérin (BCG) vaccine , which is used to prevent TB in high-risk people in some countries.

Immunization 52

Immunization Dosage Vaccines FDA 52

PharmaShots

APRIL 12, 2023

Total Revenue: $28.54B Founded Year: 1876 Total Employees: ~21,000 Headquarters: Indianapolis, United States Market Cap: $344.98B Stock Exchange: NYSE With an idea to produce quality products, Eli Lilly and Company is an American Pharmaceutical company focused on discovering, developing, manufacturing, and marketing these products.

Vaccines 64

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 64

The Checkup by Singlecare

JUNE 6, 2024

How the prescription drug law affects Jardiance In January 2023, a new prescription drug law went into effect as part of the Inflation Reduction Act. The law will allow Medicare to negotiate directly with pharmaceutical companies to improve access to affordable prescription drug costs.

Insurance 52

Insurance Vaccines Hospitals Pharmaceutical Companies 52

Roots Analysis

SEPTEMBER 9, 2024

Over the years, pharmaceutical companies have shifted their priorities from traditional interventions towards more advanced pharmacological strategies, such as protein therapeutics. Further, $400 billion is the anticipated sales of protein-based therapeutics in 2023.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

ISPE

MAY 9, 2023

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Trudy Patterson Tue, 05/09/2023 - 09:34 Features May / June 2023 Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Scott Fotheringham, PhD 1 May 2023 North Carolina’s Research Triangle is the largest of its kind in the US.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

Roots Analysis

JANUARY 24, 2024

For decades, pharmaceutical companies have manufactured drugs using batch processing in which a specific quantity of a drug is produced through multiple sequential steps. It is interesting to note that close to 50% of these companies are large and very large firms, indicating the presence of well-established players in this market.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Vaccines 40

ISPE

JANUARY 3, 2023

Tue, 01/03/2023 - 07:38. 1 January 2023. A landmark project for a major international pharmaceutical company was the starting point for a series of follow-up projects in Switzerland and Germany. . Seamless Integration with Any Automation Environment. Trudy Patterson. Sponsored Content.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 52

pharmaphorum

FEBRUARY 16, 2022

The VPAS is due to end on the 31 December 2023 and traditionally negotiations on a successor deal begin around 18 months before the end date. Ensuring wider use of new medicines is what will make the UK market really attractive to pharmaceutical companies. This is stark in comparison to the 5.1 percent rate for 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 64